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The error-related negativity (ERN) is a negative deflection in the event-related potential that occurs approximately 50ms following the commission of an error at
fronto-central electrode sites. Previous models suggest
dopamine plays a role in the generation of the ERN.
We recorded event-related potentials (ERPs) while 279
children aged 5–7 years completed a simple Go/No-Go
task; the ERN was examined in relation to the dopamine
D2 receptor (DRD2 ) and dopamine transporter (DAT1)
genes. Results suggest an additive effect of the DRD2
and DAT1 genotype on ERN magnitude such that children with at least one DRD2 A1 allele and children with
at least one DAT1 9 allele have an increased (i.e. more
negative) ERN. These results provide further support for
the involvement of dopamine in the generation of the
ERN.
Keywords: DRD2, DAT1, error-related ERPs, error-related
negativity, performance monitoring
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The error-related negativity (ERN) is a neural measure of
action monitoring that has been proposed as a possible
endophenotype for anxiety and depressive disorders (Olvet
& Hajcak 2008). The ERN is a negative deflection at frontocentral electrodes in the response-locked event-related brain
potential, occurring 50 milliseconds after the commission of
errors compared to correct responses in speeded reaction
time tasks (Falkenstein et al . 1991; Gehring et al . 1993;
Hajcak et al . 2005). It is thought to reflect activation of
a generic error detection system that is evident across a
variety of stimulus and response modalities (Gehring et al .
1993; van Veen & Carter 2002) and to be generated in
the Anterior Cingulate Cortex (ACC) (Dehaene et al . 1994;
Holroyd et al . 1998; Mathalon et al . 2003; van Veen & Carter
2002).

The ERN appears to be related to variation in trait anxiety
(Amodio et al . 2008; Boksem et al . 2006; Endrass et al . 2008;
Hajcak et al . 2003a; Weinberg et al . 2010), but not associated
with state-related changes (Hajcak et al . 2008; Moser et al .
2005). Increased ERN amplitudes have been observed in
unaffected first-degree relatives of obsessive compulsive
disorder (OCD) patients (Riesel et al . 2011). Additionally, a
twin study has shown ERN amplitudes to be significantly
heritable (40–60%) (Anokhin et al . 2008). Taken together,
these studies suggest that the ERN may meet all of the
criteria for an endophenotype related to anxiety disorders
(Gottesman & Gould 2003; Olvet & Hajcak 2008).
According to the reinforcement learning theory of the
ERN, the ERN results from the disinhibition of the ACC by
dopamine neurons when the basal ganglia evaluate ongoing
actions as worse than expected (Holroyd & Coles 2002).
Supporting the involvement of dopamine in the generation
of the ERN, administration of a dopamine agonist (Damphetamine) leads to an increased ERN amplitude (De
Bruijn et al . 2004) and the administration of a dopamine
antagonist (i.e. haloperidol) leads to a decreased ERN
(De Bruijn et al . 2006; Zirnheld et al . 2004). Additionally,
several studies have found that individuals with Parkinson’s
disease, which is characterized by dopamine depletion,
have a diminished ERN (Jocham & Ullsperger 2009; Ito
& Kitagawa 2006; Stemmer et al . 2004; Willemssen et al .
2008). Suggesting some specificity between dopamine and
the ERN, one study found that the selective serotonin
reuptake inhibitor paroxetine had no effect on ERN amplitude
(De Bruijn et al . 2006).
In light of these data, it may be fruitful to examine associations between the ERN and genetic polymorphisms related
to variation in dopamine. This study examined two dopamine
genes: D2 dopamine receptor (DRD2 ) gene and dopamine
transporter gene (DAT1 or SCL6A3 ).
The DRD2 gene located on chromosome 11q, encodes
the D2 subtype of the dopamine receptor. The Taq1 A1
polymorphism (rs1870497) of the DRD2 gene has been
related to reduced D2 dopamine receptor binding affinity
(Noble 2003), and more specifically to lower dopamine
receptor density in the striatum (Jonsson et al . 1999). An
in vivo positron emission tomography (PET) study suggested
that individuals with the A1 allele are characterized by a
significant decrease in DRD2 receptor availability in the
striatum relative to individuals homozygous for the A2 allele
(Pohjalainen et al . 1998a) and a post-mortem study found
fewer D2 receptors in the brains of individuals with the
A1 allele. Importantly, evidence suggests that carriers of
the A1 allele have upregulated synthesis of dopamine in
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the brain due to decreased autoreceptor function (Laakso
et al . 2005). Based upon the pharmacological findings
previously discussed, carriers of the A1 allele may exhibit
an increased ERN due to increased availability of dopamine.
In general, adults have fewer D2 receptors than children
(Seeman et al . 1987) and women may have fewer D2
receptors in the striatum than men (Pohjalainen et al . 1998b).
Studies of animals and humans have linked the DRD2
polymorphism to impaired social functioning and anxious
and depressive symptoms (Hayden et al . 2010; Lawford
et al . 2006; Schneier et al . 2000; Shively et al . 1997).
The second dopamine gene examined was DAT1, which
is located on chromosome 5p15.3 and codes for a dopamine
transporter protein that terminates synaptic transmission
by the reuptake of dopamine into the presynaptic neuron
(Amara & Kuhar 1993; Giros & Caron 1993; Fuke et al . 2001;
Vandenbergh et al . 1992). The two most prevalent variants
are the 9-repeat and 10-repeat alleles; individuals with the
9-repeat, in normative samples, have been shown to have
more DAT protein availability in the striatum (Jacobsen et al .
2000; Van de Giessen et al . 2009; van Dyck et al . 2005). One
study found an association between the 10-repeat allele and
hypoactivation in the left anterior cingulate cortex compared
to 9-repeat carriers, suggesting that the 10-repeat allele
may be associated with a smaller ERN (Brown et al . 2010).
The DAT1 has been examined in association with attention
deficit hyperactivity disorder (ADHD) (Faraone et al . 2005),
hyperactivity (Diamond 2007), novelty seeking (Sabol et al .
1999), delay aversion and motor functions (Heinz et al . 2000),
alcohol withdrawal symptoms (Sander et al . 1997), PTSD
(Segman et al . 2002), and generalized anxiety, social phobia,
OCD and Tourette’s in children (Rowe et al . 1998).
In adults, two previous studies have investigated the role
of the DRD2 (Mueller et al . 2011) and DAT1 (Biehl et al .
2011) polymorphisms in the generation of the ERN, both
finding no association. The ERN has recently begun to be
examined in children, suggesting that although it may be
slightly more posterior, it is both spatially and temporally
similar to the ERN in adults (Brooker et al . 2011; Ladouceur
et al . 2007; Meyer et al . 2012; Torpey et al . 2009) and has
been shown to increase in magnitude with age (Davies et al .
2004; Torpey et al . 2011). Thus, both the ERN (Davies et al .
2004; Torpey et al . 2011) and dopamine systems (Fareri et al .
2008) are known to change across the lifespan, and therefore
may relate to one another differently among children than
in adults. In children, two previous studies of the same
sample reported no independent association of DRD2 and
DAT1 genotypes with the ERN (Althaus et al . 2009, 2010).
However, the sample was comprised of 65 children, most
of them with a diagnosis of either Pervasive Developmental
Disorder or ADHD. No study to date has examined the
relationship between these two dopamine genotypes and
ERN in a large normative sample of children.
In this study, ERPs were recorded while 279 children aged
5–7 years completed a simple Go/No-Go task. Information
about each child’s dopamine genotypes (DRD2 and DAT1)
was collected to investigate potential relationships between
the ERN and dopamine-related gene polymorphisms. Given
that the DRD2 A1 allele has been associated with an
upregulation of dopamine and the DAT1 9 allele has
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been associated with increased activation of the ACC, we
expected that children with the DRD2 A1 allele and children
with the DAT1 9 allele would have larger (i. e., more negative)
ERN amplitudes.

Method
Participants
The sample included 279 children (124 female) from a suburban
community. The original sample included 412 children. In this analysis
57 were excluded due to non-consent for genetic information and 3
were excluded because they carried a rare variant of the DAT1 gene.
Because Olvet and Hajcak (2008) found that six or more error trials
are needed for a stable ERN, data from 73 of 352 (20.74%) children
in total were excluded from further analyses.
The mean age of the children was 6.10 years, SD = 0.43, range =
5.15–7.57 years at the time of the laboratory visit. The children were
part of a larger study that involved an initial assessment approximately
3 years prior. Originally, potential participants were identified through
a commercial mailing list. Eligible families were contacted by the
Stony Brook University Center for Survey Research and had a child
between 3 and 4 years of age, with no developmental disability
or significant medical conditions, and at least one English-speaking
biological parent. In the overall sample, 87.4% of the children were
Caucasian, 69.3% had at least one parent who was a college graduate
and 95.4% came from two-parent homes.

Genetic analysis
When participants came to the laboratory for the initial assessment,
buccal cells were collected for genetic analysis by rubbing the inside
of each child participant’s cheek with two swabs. The Qiagen DNA
Micro Kit (Qiagen, Valencia, CA, USA) was used to extract genomic
DNA from buccal swab samples according to the manufacturer’s
instructions. Extracts were kept at 4◦ C when being analyzed, and
were held at −80◦ C for long-term storage. Polymerase chain reaction
(PCR) was carried out using the Applied Biosystems thermal cycler
Gene Amp 9700 (Applied Biosystems, Foster City, CA, USA), and
PCR products were separated on 6% polyacrylamide gels, stained
with ethidium bromide, and visualized and documented by a UV
imaging system (BioRad Labs, Mississauga, Ontario, Canada).
For the detection of the DRD2 Taq1A polymorphism, oligonucleotide primers 5 -CACGGCTGGCCAAGTTGTCTA-3 (forward) and

5 -CACCTTCCTGAGTGTCATCAA-3 (reverse) were used to amplify a
300-bp region flanking the Taq1A site (Grandy et al . 1993). The PCR
conditions used were initial denaturation for 5 min at 95◦ C followed
by 30 cycles of 30 seconds denaturation at 94◦ C, 30 seconds annealing at 58◦ C, and 30 seconds extension at 72◦ C, followed by a 5 min
final extension at 72◦ C. The amplicons were digested overnight with
1U of Taqα 1 restriction enzyme (New England BioLabs, Ipswich,
MA, USA). The A1 allele is uncut by the restriction enzyme, whereas
the A2 allele generates 125 and 175 bp fragments. Of the 279
children who provided a DNA sample, 11children had the A1A1
homozygous genotype, 80 were heterozygous (A1A2) and 188 had
the A2A2 homozygous genotype. These genotype frequencies are in
Hardy–Weinberg equilibrium χ 2 (1)= 0.56, P = 0.45. All genotyping
was performed by research technicians blind to other study data.
Consistent with most published research, and considering the rarity
of the A1A1 genotype, groups for data analysis were formed based on
whether children had (N = 91) or did not have (N = 188) an A1 allele.
A 40 nucleotide VNTR polymorphism has been identified within the
3 non-coding region of the DAT1 gene. Alleles of this VNTR sequence
range from 3 to 13 repeats, but the 9-repeat and 10-repeat alleles are
the most common (Palmatier et al . 1999). For this study, the primers
used were 5 -TGTGGTGTAGGGAACGGCCTGAG-3 (forward) and
5 -CTTCCTGGAGGTCACGG CTCAAGG-3 (reverse). PCR conditions
were as follows: 5 min initial denaturation at 95◦ C and 30
cycles of 30 seconds initial denaturation at 94◦ C, 45 seconds
annealing at 67.5◦ C, 45 seconds extension at 72◦ C, followed by
5 min of final extension at 72◦ C. The 9-repeat and 10-repeat
Genes, Brain and Behavior (2012) 11: 695–703
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products yield a 440- and 480-bp fragment, respectively. Of
those 279 children we were successfully able to genotype
for the DAT1 allele, 138 of them were homozygous for the
DAT1 10R allele, 24 of them were homozygous for the 9R
allele, and 117 were 9R/10R heterozygous. These genotype
frequencies are in Hardy–Weinberg equilibrium χ 2 (1) = 0.01,
P = 0.92. Three of the children had an unusual variant (the
11R) and have been excluded from the analysis. Consistent
with previous studies (Althaus et al . 2010), two groups were
formed based on whether children were homozygous for the
10R allele (138 children) or carried at least one 9R allele
(141 children). Additionally, the results of a chi-square test of
independence suggest that the variants of the two genotypes
(DRD2 and DAT1) are independent, χ 2 (1, N = 279) = 0.26,
P = 0.61.

Task and materials
A Go/No-Go paradigm, described previously in Torpey et al . (2011),
was administered using Presentation software (Neurobehavioral Systems, Inc., Albany, CA, USA). The stimuli were green equilateral
triangles in four different orientations. There were a total of 240
trials, 60% of the triangles were vertically aligned and pointed up,
20% were vertically aligned and pointed down, 10% were tilted
slightly to the left, and 10% were titled slightly to the right. Children
were instructed to respond to upward-pointing triangles by pressing
a button, and to withhold responses to all other stimuli.

Procedure
A series of practice blocks were administered to ensure that the participant understood the various aspects of the task. After completing
the practice blocks, children were instructed that for each block, they
would earn one point for correct responses on Go trials and for withholding responses on No-Go trials. They were told that if they earned
enough points, they could win up to $5.00. Speed of response
was again emphasized to the children. Between each block, the
experimenter told the participants how many points they earned and
reminded the children of the task instructions, emphasizing response
speed.

Psychophysiological recording
Data were acquired using the Active Two system (Biosemi, Amsterdam, The Netherlands). 32 Ag/AgCl-tipped electrodes arranged
according to the American Electroencephalographic Society labeling
system (1994) were used with a small amount of electrolyte (Signa
Gel; Bio-Medical Instruments Inc., Warren, MI, USA) applied to the
child’s scalp at each electrode position. For more information on data
acquisition, see Torpey et al . (2011).
Offline, all data processing was performed with Brain Vision Analyzer (Brain Products, Gilching, Germany). Electroencephalogram data
was re-referenced to the nose, and high- and low-pass filtered at 1
and 30 Hz, respectively. From the continuous EEG, 1500 milliseconds
segments were extracted beginning 500 milliseconds prior to correct
and erroneous responses. ERP data were corrected for blinks and
eye-movements using the method developed by Gratton, Coles, and
Donchin (1983). Additional artifacts were rejected when any of the
following criteria are met: a voltage step of more than 50 μV between
data points, a voltage difference of 300 μV within a single trial or a
voltage difference of less than 0.5 μV within 100 milliseconds intervals. Data were also visually inspected for any remaining artifacts.
ERP averages were then created separately for each trial type (correct
and error) and were baseline corrected by subtracting from each data
point the average activity the −500 to −300 milliseconds window
prior to the response. Trials were not included in ERP averages if the
reaction time occurred outside of a 200–1300 milliseconds window.
The ERP and behavioral results in the full sample have been
reported previously (Torpey et al . 2011). In this study, we focus on the
impact of DRD2 and DAT1 genotype on the error-related negativity
(ERN) and correct-related negativity (CRN), which were scored at Cz
as the average voltage in the window from 0 to 100 milliseconds
after the response, where error-related brain response was maximal
Genes, Brain and Behavior (2012) 11: 695–703

(Torpey et al . 2011). The ERN can be calculated by averaging the
error-trial waveform or by subtracting the correct-trial waveform
from the error-trial waveform (i.e. ERN) (Pailing et al . 2002). The
ERN on error trials alone likely includes processes common to both
error and correct responses. By subtracting correct from error trials
(ERN), processes common to both correct and error responses are
removed, resulting in a measure of neural activity specific to errors.
Thus, all analyses examined the CRN, ERN and ERN.
Behavioral measures included both the number of errors of
commission and omission for each subject. Average reaction times
(RTs) on error and correct trials were also calculated separately, as
were RTs on correct trials that followed errors trials to evaluate
post-error RT slowing. Trials were removed from all analyses if
reaction times were faster than 200 milliseconds or slower than
1300 milliseconds.
Statistical analyses were conducted using SPSS (Version 17.0)
General Linear Model software, with Greenhouse-Geisser correction
applied to P values associated with multiple-df, repeated-measures
comparisons when necessitated by violation of the assumption of
sphericity. Analyses were structured with the goal of finding main
effects as well as interactive or additive effects of child DRD2 and
DAT1 genotypes on the ERN, CRN and ERN. Repeated measures
analysis of variances (ANOVAs) were conducted, with response type
(i.e. CRN and ERN) as a within-subject variable and DRD2 and DAT1
genotypes as between-subjects variables. Follow-up one-way ANOVAs
were conducted to determine how each genotype specifically related
to CRN, ERN and ERN. Additionally, hierarchical multiple regression
analyses were performed to confirm that the effects of DRD2
and DAT1 were additive on ERN. A follow-up repeated measures
ANOVA was conducted with age, reaction time, and accuracy as
covariates, followed by a mediation analysis. Finally, post hoc ANOVAs
were conducted to investigate the potential role of gender in the
relationship between the dopamine genotypes and ERN.

Results
Because of technical error, the behavioral data from six participants were lost; however, the ERP data for these subjects
were included in the analyses. This left a total of 273 subjects that could be included in the behavioral analyses and
279 subjects included in the ERP and genetic analyses.

Behavioral data
Performance measures in the overall sample, and as a function of DRD2 and DAT1 genotype, are presented in Table 1.
Consistent with previous work, children were significantly
faster on error trials than on correct go trials, t (1, 272)
= 32.42, P < 0.001. Compared to the overall mean of correct trial reaction time, participants were slower to generate
a correct response on trials that occurred after an error, t (1,
272) = 5.90, P < 0.001. However, there were no overall reaction time differences as a function of either DRD2 or DAT1
genotype, F1,269 = 0.02, P = 0.89, F1,269 = 2.90, P = 0.09,
respectively; neither DRD2, F1,269 = 0.71, P = 0.40, nor
DAT1, F1,269 = 0.46, P = 0.50, interacted with trial type
to impact reaction time. However, there was a three-way
interaction between trial type, DRD2, and DAT1, F1,269 =
4.56, P < 0.05.
As depicted in Fig. 3, post-hoc t -tests suggested that
within the DRD2 A1 group, children who were homozygous for DAT1 10/10, were slower on correct trials than
children with a DAT1 9 allele, t (1, 88) = −2.65, P < 0.01.
Within the DRD2 A1 group, reaction time on error trials did
not differ significantly between the two DAT1 genotypes,
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Table 1: Means (SD) of behavioral measures (milliseconds), ERN, CRN and (ERN–CRN) amplitude (μV) at Cz for the entire sample and
the genotypes
All children (N = 279) DRD2 A1 (N = 91) DRD2 A2/A2 (N = 188) DAT1 10/10 (N = 138) DAT1 9 (N = 141)
Errors of commission
Errors of omission
RT errors
RT correct
Post-error RT
Post-error slowing
ERN
CRN
ERN

16.01 (7.62)
10.12 (11.05)
509 (88)
626 (72)
655 (119)
28 (79)
0.09 (10.06)
9.18 (5.94)
−9.09 (10.26)

15.57 (6.51)
8.68 (9.58)
511 (94)
624 (77)
647 (116)
22 (81)
−2.03 (7.37)
9.32 (5.55)
−11.35 (8.28)

16.37 (8.10)
10.83 (11.66)
507 (85.26)
627 (70)
660 (121)
32 (81)
1.12 (10.99)
9.11 (6.13)
−7.99 (10.95)

17.05 (8.13)
11.60 (12.06)
514 (92)
632 (71)
655 (112)
23 (73)
0.79 (11.34)
8.56 (6.13)
−7.78 (11.99)

1520 (7.01)
8.71 (9.83)
503 (84)
621 (72)
656 (126)
35 (89)
−0.59 (8.61)
9.78 (5.70)
−10.37 (8.07)

Table 2: Overall and Incremental results from hierarchical
regression analysis of genotype predicting ERPs at Cz
ERN

R

2

Overall results
Step 1: DRD2 0.022
Step 2: DAT1
0.025
Incremental results
Step 1: DRD2 0.02
Step 2: DAT1
0.004

CRN

F

R

6.11∗∗
3.64∗
6.11∗∗
1.17

2

ERN
2

F

R

F

0.00
0.01

0.072
1.49

0.024
0.038

6.67∗∗
5.52∗∗

0.00
0.01

0.072
2.91

0.024
0.015

6.67∗∗
4.28∗

t (1, 88) = −1.01, P = 0.32. Within the DRD2 A2/A2 group,
neither correct, t (1, 181) = 0.36, P = 0.72, nor error reaction times, t (1, 181) = −.59, P = 0.56, differed significantly
between the DAT1 groups.
Additionally, post-error slowing did not differ by DRD2
genotype, F1,272 = 0.64, P = 0.42, or by DAT1 genotype,
F1,272 = 0.004, P = 0.95, and there were no significant twoor three-way interactions involving genotypes and post-error
slowing (all ps > 0.1).
Overall, participants committed an average of 16.10,
SD = 7.62, errors of commission and an average of 10.12,
SD = 11.05, errors of omission, out of a total of 240 trials.
Children with at least one DAT1 9 allele made significantly
fewer errors of commission and fewer errors of omission
than children who were homozygous for the DAT1 10
allele, F1,272 = 4.08, P < 0.05 and F1,272 = 4.75, P < 0.05,
respectively. All other effects and interactions did not reach
significance (all ps > 0.1).

ERPs
Means and standard deviations of ERN, CRN and ERN as
a function of genotype are included in Table 2, responselocked waveforms at Cz for ERN and CRN for each genotype
are included in Figs 1 and 2. The ERP response was more
negative following errors than correct responses, F1,275 =
222.25, P < 0.001. There was no overall difference in brain
activity as a function of the DRD2 or DAT1 genotypes,
F1,275 = 2.98, P < 0.09, and F1,275 = 0.51, P = 0.48,
respectively. However, the effect of trial type was qualified by
a significant interaction with DRD2 genotype, F1,275 = 6.37,
P < 0.01. Children with at least one DRD2 A1 allele had a
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DRD2 A1

DRD2 A2/A2

Figure 1: Response-locked waveforms at Cz for ERN and
CRN for DRD2 genotype.

larger (i.e. more negative) ERN than children who were
homozygous for the DRD2 A2 allele, F1,277 = 6.67, P < .01.
This effect was driven by the effect of DRD2 genotype
on the ERN, F1,277 = 6.11, P < 0.01 such that children
carrying at least one DRD2 A1 allele had a significantly
larger (i.e. more negative) ERN than children carrying the
DRD2 A2 allele (homozygous for A2). Children did not differ
in CRN between the two DRD2 genotypes, F1,277 = 0.072,
P = 0.79.
In addition, the difference between ERN and CRN also
varied as a function of DAT1 genotype, F1,275 = 3.88,
P < 0.05. Although neither the ERN nor the CRN differed
Genes, Brain and Behavior (2012) 11: 695–703
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dependent variables and potential predictor variable were the
DRD2 and DAT1 genotypes. Results are shown in Table 2. As
can be seen from the table, the additional variance accounted
for in the ERPs by adding DAT1 as a predictor was significant
in the case of ERN, R2 = 0.015, P < 0.05, although not
in any of the other ERP measures. The variance in the
difference score ERN accounted for by DRD2 alone was
2.4% and after DAT1 was added, the variance accounted for
increased to a total of 3.8%, a significant increment. Thus,
DAT1 significantly predicts the difference score ERN even
after controlling for DRD2. This suggests an additive effect
of the two genotypes. Overall and incremental results from
the hierarchical regression analyses are included in Table 2.

Mediation analysis

Dat1 10/10

Figure 2: Response-locked waveforms at Cz for ERN and
CRN for DAT1 genotype.

between the two genotypes alone, F1,277 = 1.32, P = 0.25
and F1,277 = 2.95, P = 0.09, respectively, children with the
DAT1 10 allele (homozygous for DAT1 10) had a significantly
smaller (i.e. less negative) ERN than children with the
DAT1 9 allele (with at least one DAT1 9 allele), F1,277 = 4.53,
P < 0.05.
Neither the DAT1 by DRD2 two-way interaction, F1,275 =
3.62, P = 0.06, nor the three-way interaction between
trial type, DAT1 genotype, and DRD2 genotype reached
significance, F1,275 = 0.01, P = 0.92, suggesting two
independent effects on error-related brain response related
to the DAT1 and DRD2 genes. To investigate the possibility
that the genotypes related differently to frontal/posterior
electrode sites, a repeated-measures ANOVA was conducted
that suggested that the effect of trial type at Pz was also
qualified by a significant interaction with the DRD2, F (1,
275) = 6.053, P < 0.01, and the DAT1 genotype, F (1, 275)
= 6.46, P < 0.01. An additional repeated-measures ANOVA
suggested that the effect of trial type at Fz was qualified by
a significant interaction with the DRD2 genotype, F (1,275)
= 5.74, P < .05, but not the DAT1 genotype, F (1,275) = 2.51,
P = 0.12.).

Hierarchical multiple regression analyses
To test for unique contribution of each genotype on the ERN,
CRN and ERN we conducted separate hierarchical multiple
regression analyses in which each of the ERPs were the
Genes, Brain and Behavior (2012) 11: 695–703

Gender
A follow-up repeated measure ANOVA suggested that when
gender was added as a covariate, it did not result in a
significant interaction with ERN, F1,274 = 0.16, P = 0.69, and
the interaction of DRD2 and ERN, F1,274 = 6.35, P < 0.01,
and DAT1 and ERN, F1,274 = 3.99, P < 0.05, remained
significant. However, a previous study has suggested that
**
650
640
Correct RT (msec)

Dat1 9

A follow-up repeated measure ANOVA suggested that when
overall accuracy, reaction time (on error and correct trials),
and age are added as covariates, the interaction between trial
type and DRD2 remained significant, F1,265 = 6.07, P < 0.01,
however, the effect of trial type was no longer qualified by
the interaction with DAT1, F1,265 = 1.94, P = 0.17. Statistical
analyses were conducted to test the potential mediation of
accuracy on the relationship between DAT1 and ERN. The
original beta for the relationship between DAT1 and ERN was
2.60, t (278) = 2.13, P < 0.05 and the beta for the relationship
between DAT1 and accuracy was −4.75, t (272) = −2.73,
P < 0.01. In the second regression analysis, the beta for
accuracy predicting ERN was -.12, t (272) = −2.51, P < 0.01
and the beta for DAT1 predicting ERN was reduced to 2.03,
t (272) = 1.63, P = 0.12. This reduction was significant;
Sobel’s test Z = 1.85, P < 0.05 (Fig. 3).
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Figure 3: Correct reaction time (milliseconds) for the combined genotype groups and significance for post hoc t -tests.

699

Meyer et al.

males and females differ in DRD2 binding in the striatum
(Pohjalainen et al . 1998b) so further post hoc analyses were
completed by dividing the sample into males and females. In
males, the effect of trial type was not significantly qualified by
an interaction with DRD2 genotype, F1,155 = 0.88, P = 0.35.
However, in females there was a significant interaction of
trial type with DRD2 genotype, F1,123 = 7.20, P < 0.01, such
that females with the DRD2 A1 allele had a significantly more
negative ERN, M = −3.67, SD = 7.53, than females without
the DRD2 A1 allele, M = 1.01, SD = 11.04.

Discussion
The results of this study suggest that there is an additive
effect of the DRD2 and DAT1 genotype on ERN magnitude
such that children with at least one DRD2 A1 allele and
children with at least one DAT1 9 allele have an increased
(i.e. more negative) ERN. This finding fits with the notion
that the ERN is related to a reduction in dopaminergic activity
seen on error trials when an expected reward is not delivered
(Holroyd & Coles 2002).
Studies have suggested that the generation of the CRN
may be due to error processing during correct trials (Coles
et al . 2001); for instance, there is an increase in CRN
amplitude as a function of subjectively rated inaccuracy
on correct trials (Scheffers & Coles 2000). Although the
children with the DAT1 9 allele did display a larger (i.e. more
negative) ERN on error trials, they were also characterized
by a smaller (i.e. less negative) CRN on correct trials – and
better performance overall. It could be that these children
were more accurate in judging when they had actually
made an error and thus had a smaller CRN and larger
ERN. This increased performance could be due to enhanced
perceptual or attentional abilities. In fact, the DAT1 10/10
allele has previously been associated with attention deficit
hyperactivity disorder (Faraone et al . 2005; Thapar et al .
2005), and decreased selective attention and response
inhibition (Cornish et al . 2005).
Additionally, children with the DAT1 9 allele committed
fewer errors of commission and omission, and within the
DRD2 A1 group, children with the DAT1 9 allele were faster
on correct trials. In this sample, the magnitude of ERN
was previously related to better performance, indicated
by greater accuracy, more correct No-Go trials and fewer
errors of commission and omission (Torpey et al . 2011). And,
previous studies have consistently found that ERN amplitude
is increased when people make fewer errors (Amodio et al .
2008; Hajcak et al . 2003b). Additional statistical analyses
were consistent with the hypothesis that increased accuracy
may have driven the relationship observed between the
DAT1 9 allele and increased ERN.
Overall, these findings fit with a previous study suggesting
that children with the short variant of the 5-HTTLPR gene
and also with a DRD2 A1 allele had a larger ERN (Althaus
et al . 2009). While previous investigations of the relationship
between the DAT1 genotype and ERN did not find a
significant independent effect, this may have been due
to a small sample size or in the study examining adults,
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age-related changes in dopamine transporter density (Althaus
et al . 2010; Biehl et al . 2011). In fact, a previous study
suggests that dopamine transporter density declines with
age in a linear manner (Innis et al . 2002). It is important
to note that one study found an association in adults with
the DRD2 A1 allele and a reduced negative feedback-related
fMRI signal in the rostral cingulate zone (Klein et al . 2007).
However, this study included only male participants and
it has been suggested that females may have a lower
DRD2 binding affinity (Pohjalainen et al . 1998b). Followup analyses in our sample suggested that the relationship
between the DRD2 A1 allele and ERN was only apparent in
females. It may be that females have fewer D2 receptors
and that females with the DRD2 A1 allele have even fewer
receptors, contributing to a larger ERN. Future studies should
investigate the possibility that the relationship between the
DRD2 genotype and ERN may vary depending on gender.
In a previous paper, we reported a significant relationship
between the DRD2 A1 allele and anxious symptoms
emerging around age 3 (Hayden et al . 2010). A tentative
possibility is that one mechanism through which the DRD2
A1 allele relates to enhanced anxiety in young children
is by increased error monitoring related to fewer D2
receptors in the striatum. However, more research in
this area is needed to substantiate this. Traditionally, the
DRD2 A1 allele has been studied in adults in relationship
to substance abuse (Dick & Foroud 2003) and a recent
study suggests that an increased ERN is found in alcoholdependent patients, especially those with comorbid anxiety
disorders (Schellekens et al . 2010). Additionally, some
evidence suggests anxiety may be a risk factor for the
development of substance abuse problems (Cimander et al .
2001; Grant et al . 2004; Sartor et al . 2007). It is possible
that the DRD2 A1 allele is related to an underlying liability to
anxiety in childhood that transitions into a substance abuse
trajectory by adulthood.
It is also important to note that the relationships observed
between the two dopamine genes and ERN were found in a
sample of young children. Indeed, the amplitude of the ERN
increases with age (Davies et al . 2004; Torpey et al . 2011),
D2 receptor expression in the striatum increases in childhood
until age 5 and then decreases into adulthood (Seeman
et al . 1987), and dopamine transporter density declines with
age (Innis et al . 2002). Taken together, it is possible that
the relationships observed between dopamine genotypes
and ERN may vary as a function of age. Additionally,
it is possible that genetic variants may have different
functional consequences across development (Wahlstrom
et al . 2007). Limited research has been done on this topic
for the DRD2 and DAT1 genotypes, therefore generalizing
research in children to adults and vice versa must be
done cautiously. Prospective studies on the relationship of
dopamine genes and ERN across development are needed
to clarify this and also shed light on the hypothesized
causal relationship between the genotypes and ERN. We are
currently investigating this issue in ongoing and longitudinal
studies.
This study is the first to find independent effects of
two dopamine genes on ERN. This finding supports the
reinforcement learning theory that suggests the ERN is
Genes, Brain and Behavior (2012) 11: 695–703
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related to a reduction in dopaminergic activity seen on
error trials when an expected reward signal is not delivered
(Holroyd & Coles 2002). Additionally, the association
between candidate genes and the ERN may provide a
potential mechanism through which the DRD2 and DAT1
genotypes relate to clinical phenotypes. Future research
in adolescents and adults is needed to investigate the
association of other dopamine genes (specifically: Dopamine
receptor D4 and Catechol-O-methyltransferase) and errorrelated neural activity, and how dopamine-mediated errorrelated brain activity relates to clinical disorders across
development.
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